Studies investigating the mechanisms underlying the pro-tumorigenic effects of Smad7 identified thioredoxin-1 and retinoblastoma as key molecules involved in the Smad7-dependent aggressiveness of pancreatic cancer cells [70,71]. This evidence concerns the gene SMAD7 and familial pancreatic carcinoma.